Black Americans are more likely to get pancreatic cancer than any other racial or ethnic group, according the National Cancer ...

The FDA has granted orphan status to Arcus Biosciences’ CD73 inhibitor quemliclustat for metastatic pancreatic cancer, as the ...

Arcus Biosciences announced that the Food and Drug Administration has granted its pancreatic cancer treatment, quemliclustat, with an orphan drug designation. The company said it expects its ongoing ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today ...

Daraxonrasib gains FDA breakthrough therapy status for treating metastatic pancreatic cancer with KRAS G12X mutations, ...

Dr. Anandhan's research marks a significant step forward in the fight against pancreatic cancer, offering renewed hope for ...

The Pancreatic Cancer Action Network (PanCAN), the leading nonprofit organization dedicated to [...] READ MORE ...

Benzaldehyde – a compound responsible for the aroma of almonds, apricots and figs – halts the growth and spread of ...

Geneticist Nilabja Sikdar in Calcutta, with collaborators in Jadavpur University, Israel and the US, has found that patients ...